Boundless Bio, Inc.

BOLD · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$13,879-$15,675-$15,758-$16,448
Dep. & Amort.$310$317$317$296
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,303$1,693$1,797$2,008
Change in WC$1,847$1,711-$927-$1,126
Other Non-Cash$224$125$41-$293
Operating Cash Flow-$10,195-$11,829-$14,530-$15,563
Investing Activities
PP&E Inv.-$15-$48-$59-$466
Net Acquisitions$0$0$0$0
Inv. Purchases-$39,507-$43,660-$52,625-$47,436
Inv. Sales/Matur.$50,000$55,000$55,744$49,725
Other Inv. Act.$0$0$0$0
Investing Cash Flow$10,478$11,292$3,060$1,823
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$113
Stock Repurch.$0$117$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$117$0$113
Forex Effect$0$0$0$0
Net Chg. in Cash$283-$420-$11,470-$13,627
Supplemental Information
Beg. Cash$15,257$15,677$27,147$40,774
End Cash$15,540$15,257$15,677$27,147
Free Cash Flow-$10,210-$11,877-$14,589-$16,029
Boundless Bio, Inc. (BOLD) Financial Statements & Key Stats | AlphaPilot